Hsp72 protects against liver injury via attenuation of hepatocellular death, oxidative stress, and JNK signaling

作者：Levada Kateryna; Guldiken Nurdan; Zhang Xiaoji; Vella Giovanna; Mo Fa Rong; James Laura P; Haybaeck Johannes; Kessler Sonja M; Kiemer Alexandra K; Ott Thomas; Hartmann Daniel; Hueser Norbert; Ziol Marianne; Trautwein Christian; Strnad Pavel^*

来源：Journal of Hepatology, 2018, 68(5): 996-1005.

DOI：10.1016/j.jhep.2018.01.003

• Lipotoxicity
• Drug-induced injury
• JNK
• MCD
• DDC

Background & Aims: Heat shock protein (Hsp) 72 is a molecular chaperone that has broad cytoprotective functions and is upregulated in response to stress. To determine its hepatic functions, we studied its expression in human liver disorders and its biological significance in newly generated transgenic animals.
Methods: Double transgenic mice overexpressing Hsp72 (gene Hspa1a) under the control of a tissue-specific tetracycline-inducible system (Hsp72-LAP mice) were produced. Acute liver injury was induced by a single injection of acetaminophen (APAP). Feeding with either a methionine choline-deficient (MCD; 8 weeks) or a 3,5-diethoxycarbonyl-1,4-dihydrocolli dine-supplemented diet (DDC; 12 weeks) was used to induce lipotoxic injury and Mallory-Denk body (MDB) formation, respectively. Primary hepatocytes were treated with palmitic acid.
Results: Patients with non-alcoholic steatohepatitis and chronic hepatitis C infection displayed elevated HSP72 levels. These levels increased with the extent of hepatic inflammation and HSP72 expression was induced after treatment with either interleukin (IL)-1 beta or IL-6. Hsp72-LAP mice exhibited robust, hepatocyte-specific Hsp72 overexpression. Primary hepatocytes from these animals were more resistant to isolation-induced stress and Hsp72-LAP mice displayed lower levels of hepatic injury in vivo. Mice overexpressing Hsp72 had fewer APAP protein adducts and were protected from oxidative stress and APAP-/MCD-induced cell death. Hsp72-LAP mice and/or hepatocytes displayed significantly attenuated Jnk activation. Overexpression of Hsp72 did not affect steatosis or the extent of MDB formation.
Conclusions: Our results demonstrate that HSP72 induction occurs in human liver disease, thus, HSP72 represents an attractive therapeutic target owing to its broad hepatoprotective functions.

• 出版日期2018-5